Ray Dalio's position in Vaxcyte is currently worth $3.3M. That's 0.01% of their equity portfolio (564th largest holding). The first Vaxcyte trade was made in Q3 2025. Since then Ray Dalio bought shares two more times and sold shares on one occasions. The stake costed the investor $2.73M, netting the investor a gain of 21% so far.